$CBRS

Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It

Cerebras Systems reported Q2 adjusted revenue of $209.9M, up 103% YoY, with a $25.4B backlog driven by an OpenAI agreement. The company raised its full-year outlook to $880M-$890M. OpenAI's deal accounts for most of the backlog, with revenue recognition expected over several years. Cerebras' stock is down 44% from its 52-week high, trading at a market cap of ~$51B.

Original reporting
Published Sep 6, 2026, 12:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 6, 2026, 12:50 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It — source image
Decision brief

The 30-second read

$CBRSNeutralMed
01

Why it matters

The $25.4 billion backlog, largely from an OpenAI agreement, is a new material disclosure that shapes long‑term revenue outlook.

02

Market read

Backlog size signals robust demand for AI compute capacity, but conversion timeline tempers short‑term price expectations.

03

What to watch

Capital‑intensive build‑out risk and potential competition from other AI hardware providers.

Relevance 8/10Novelty 8/10Timing: post‑earnings Q2 2026 release

Background

Cerebras Systems, an AI‑focused chip maker, posted Q2 results with 103% YoY revenue growth and raised FY guidance.

Company-level read

Ticker impact

$CBRSNeutralHigh confidence
Context

Cerebras reported a $25.4 billion backlog in its Q2 2026 earnings, driven largely by a multi‑year OpenAI contract.

Expected impact

Potential upside if conversion accelerates; downside risk if build‑out delays or OpenAI demand wanes.

Evidence & confidence

The disclosed backlog is material and new, but revenue realization extends to 2028, limiting immediate price impact.

Market effects

Highlights growing AI infrastructure demand, benefiting semiconductor and data‑center equipment sectors.

Backlog tied to OpenAI, a US‑based AI leader, may influence US AI‑related equities.

Large multi‑year contract underscores the global scale of AI compute spending.

Counterpoint

The backlog may be overstated if OpenAI scales back or delays, keeping the stock overvalued.

Key entities

  • Cerebras Systems

    AI compute hardware provider listed on NASDAQ.

  • OpenAI

    AI model developer and major customer of Cerebras.

Related articles

$CBRSMed

Cerebras (CBRS) Plants A 165 MW Flag In Finland While Still Losing Money

Cerebras Systems (CBRS) announced a new AI data center in Finland with partner Compute Nordic Finland, set to reach 165 MW capacity. The project is backed by contracts and will be built in stages. Cerebras reported a 281% increase in cloud revenue for the quarter, but still operates at a loss. The company raised its full-year outlook but expects lower margins in the third quarter. Hedge fund ownership increased significantly, while short interest remains high.

$CBRSHighAI 8/10

Cerebras Drops 19% in 3 Months: Buy, Sell or Hold the Stock?

Cerebras Systems (CBRS) shares fell 19% in 3 months due to profitability concerns, margin pressure, and competition. Q3 2026 revenue guidance is $214-$216M, with margins expected to decline. The company faces customer concentration risks and competition from NVIDIA, AMD, and Intel. Despite strong RPO and expansion plans, near-term challenges persist. Analysts see a 56.93% upside potential.

$CBRSHighAI 8/10

CBRS Stock Surges 68% On Nasdaq Debut: Cathie Wood's ARK Buys Shares While Trimming TSMC, AMD

Cerebras Systems (CBRS) shares surged 68% on their Nasdaq debut, closing at $311.07, with a market cap of $95B. ARK ETFs bought 105,616 shares, while trimming stakes in TSMC and AMD. The IPO raised $5.6B, with strong demand highlighting investor interest in AI hardware. CBRS reported $510M in 2023 sales, up from $290.3M in 2024, and partners with OpenAI, Meta, AWS, and IBM.

$CBRSMed

CBRS Stock Slides As Cerebras Ramps AI Capacity And Growth

Cerebras Systems Inc. (CBRS) stock rose 10.73% on September 4, 2026, driven by investor optimism around AI chip adoption. The company reported Q2 2026 revenue of $510M and a loss of $451M, with a high price-to-sales multiple of 117x. Morgan Stanley reiterated its overweight rating, citing strong AI demand and partnerships. CBRS faces execution risks due to high spending on AI capacity expansion.

$CBRSMed

Cerebras Systems Stock Slides As Wall Street Backs Aggressive AI Expansion

Cerebras Systems Inc. (CBRS) stock rose 10.91% on September 4, 2026, driven by bullish sentiment around its AI chip advancements. The company reported quarterly revenue of $180.1M and a net loss of $450.5M, with a price-to-sales ratio of 117.36. Morgan Stanley reiterated its overweight rating, citing surging AI inference demand and expected revenue growth. However, risks include execution challenges in data center expansion and profitability concerns.